文献速递慢性肾脏病

新型磷结合剂枸橼酸铁中肠道吸收途径与组织分布

Route of intestinal absorption and tissue distribution of iron contained in the novel phosphate binder ferric citrate.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

研究探索枸橼酸铁(FC)所含铁的肠道吸收机制和部位。8周龄大鼠随机分为假手术或5/6肾切除(CKD)组,喂饲普通饲料或含4% FC饲料6周。CKD大鼠经FC治疗血压下降,血清尿素、磷、肌酐降低,血清铁和血红蛋白升高,结肠上皮铁含量增加,远端结肠紧密连接蛋白减少,短链脂肪酸转运体表达上调。

要点

  • FC在CKD大鼠中经远端结肠吸收,与肠上皮屏障破坏及转运体上调有关。
  • FC治疗可降低CKD大鼠血压、血清尿素、磷和肌酐,升高血清铁和血红蛋白。
  • CKD大鼠远端结肠紧密连接蛋白Occludin、JAM-1和ZO-1明显减少。

核心结论

  • FC所含铁经CKD动物远端结肠吸收,机制涉及结肠上皮屏障破坏和短链脂肪酸转运体上调。

研究设计与样本

  • 8周龄大鼠随机分为假手术或5/6肾切除(CKD)组,喂饲普通饲料或含4% FC饲料6周。

主要发现

  • FC治疗的CKD大鼠血压、血清尿素、磷和肌酐水平显著降低,血清铁和血红蛋白水平升高。
  • FC治疗的CKD大鼠降结肠上皮和上皮下壁铁含量明显增加,残肾近端小管上皮细胞有少量铁沉积。
  • 未治疗与FC治疗的CKD组或对照组之间肝组织铁含量无显著差异。
  • CKD组远端结肠上皮紧密连接蛋白Occludin、JAM-1和ZO-1明显减少。
  • CKD大鼠空肠FFA2和远端结肠FFA3表达显著降低,FC给药后明显增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anemia of chronic kidney disease (CKD) is, in part, caused by hepcidin-mediated impaired iron absorption. However, phosphate binder, ferric citrate (FC) overcomes the CKD-induced impairment of iron absorption and increases serum iron, transferrin saturation, and iron stores and reduces erythropoietin requirements in CKD/ESRD patients. The mechanism and sites of intestinal absorption of iron contained in FC were explored here. METHODS: Eight-week old rats were randomized to sham-operated or 5/6 nephrectomized (CKD) groups and fed either regular rat chow or rat chow containing 4% FC for 6 weeks. They were then euthanized, and tissues were processed for histological and biochemical analysis using Prussian blue staining, Western blot analysis to quantify intestinal epithelial tight junction proteins and real-time PCR to measure Fatty Acid receptors 2 (FFA2) and 3 (FFA3) expressions. RESULTS: CKD rats exhibited hypertension, anemia, azotemia, and hyperphosphatemia. FC-treated CKD rats showed significant reductions in blood pressure, serum urea, phosphate and creatinine levels and higher serum iron and blood hemoglobin levels. This was associated with marked increase in iron content of the epithelial and subepithelial wall of the descending colon and modest iron deposits in the proximal tubular epithelial cells of their remnant kidneys. No significant difference was found in hepatic tissue iron content between untreated and FC-treated CKD or control groups. Distal colon's epithelial tight Junction proteins, Occludin, JAM-1 and ZO-1 were markedly reduced in the CKD groups. The FFA2 expression in the jejunum and FFA3 expression in the distal colon were significantly reduced in the CKD rats and markedly increased with FC administration. CONCLUSION: Iron contained in the phosphate binder, FC, is absorbed by the distal colon of the CKD animals via disrupted colonic epithelial barrier and upregulation of short chain fatty acid transporters.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Vaziri ND, Nunes ACF, Said H, et al. Route of intestinal absorption and tissue distribution of iron contained in the novel phosphate binder ferric citrate. Nephrol Dial Transplant. 2020. PMID: 32514572. doi:10.1093/ndt/gfaa053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。